COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 1178: Articles 11771-11780  | Next

An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant viral replication in rhesus macaques
Sui, Y., Li, J., Andersen, H., Zhang, R., Prabhu, S., Hoang, T., Venzon, D., Cook, A., Brown, R., Teow, E., Velasco, J., Pessaint, L., Moore, I., lagenaur, L., Talton, J., Kramer, J., Breed, M., Bock, K., Minai, M., Nagata, B., Choo-Wosoba, H., Lewis, M., Wang, L.-X., Berzofsky, J.
10.1101/2021.10.19.464990 — Posted: 2021-10-20
Discovery of Potent Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin L
Meewan, I., Kattoula, J., Kattoula, J., Skinner, D., Fajtov, P., Giardini, M., Woodworth, B., McKerrow, J., Siqueira-Neto, J., O'Donoghue, A. J., Abagyan, R.
10.1101/2021.10.19.465036 — Posted: 2021-10-20
Transcriptome data from human nasal epithelial cells infected by H3N2 influenza virus indicate early unbalanced ROS/RNA levels, temporarily increased aerobic fermentation linked to enhanced α-tubulin and rapid energy-dependent IRF9-marked immunization
Costa, J. H., Aziz, S., Arnholdt-Schmitt, B.
10.1101/2021.10.18.464828 — Posted: 2021-10-20
Major complex trait for early de novo programming 'CoV-MAC-TED' detected in human nasal epithelial cells infected by two SARS-CoV-2 variants is promising for designing therapeutic strategies
Costa, J. H., Aziz, S., Arnholdt-Schmitt, B.
10.1101/2021.10.19.464952 — Posted: 2021-10-20
Neutralization of Mu and C.1.2 SARS-CoV-2 Variants by Vaccine-elicited Antibodies in Individuals With and Without Previous History of Infection
Tada, T., Zhou, H., Dcosta, B. M., Samanovic, M. I., Cornelius, A., Herati, R., Mulligan, M. J., Landau, N. R.
10.1101/2021.10.19.463727 — Posted: 2021-10-20
Preparation of ingestible antibodies to neutralize the binding of SarsCoV2 RBD (receptor binding domain) to human ACE2 Receptor
Kadiyala, G., Iyer, S., Meher, K., Vangala, S., Chandran, S., Saxena, U.
10.1101/2021.10.19.464951 — Posted: 2021-10-20
Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice
Brooks, S. D., Smith, R. L., Moreira, A. d. S., Ackerman, H.
10.1101/2021.10.19.465025 — Posted: 2021-10-20
Repurposed nystatin to inhibit SARS-CoV-2 and mutants in the GI tract
Virag, E., Seffer, D., Penzes-Huvos, A., Varajti, K., Hegedus, G., Jankovics, I., Pallos, J. P.
10.1101/2021.10.19.464931 — Posted: 2021-10-20
Intensive Single Cell Analysis Reveals Immune Cell Diversity among Healthy Individuals
Kashima, Y., Kaneko, K., Reteng, P., Yoshitake, N., Runtuwene, L. R., Nagasawa, S., Onishi, M., Seki, M., Suzuki, A., Sugano, S., Sakata-Yanagimoto, M., Imai, Y., Nakayama-Hosoya, K., Kawana-Tachikawa, A., Mizutani, T., Suzuki, Y.
10.1101/2021.10.18.464926 — Posted: 2021-10-20
Hymecromone: A Clinical Prescription Hyaluronan Inhibitor for Efficiently Blocking COVID-19 Progression
Yang, S., Ling, Y., Zhao, F., Li, W., Song, Z., Wang, L., Li, Q., Liu, M., Tong, Y., Chen, L., Ru, D., Zhang, T., Zhou, K., Zhang, B., Xu, P., Yang, Z., Li, W., Song, Y., Xu, J., Zhu, T., Shan, F., Yu, W., Lu, H.
10.1101/2021.10.19.21263786 — Posted: 2021-10-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).